Company
IsraelPublic company, NYSE: TEVATeva Pharmaceutical Industries Ltd. (NYSE: TEVA), Jerusalem, Israel – FDA Inspections
Inspection records and compliance data for Teva Pharmaceutical Industries Ltd. in Jerusalem. 3 FDA inspections on record, last inspected July 18, 2019. Publicly traded as NYSE: TEVA.
Company Profile
This profile covers Teva Pharmaceutical Industries Ltd. based in Jerusalem, Israel.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 1
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected January 8, 2015. Last inspected July 18, 2019.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 18, 2019 | NAI | Human Drugs · Drug Quality Assurance | 1102103 |
| September 15, 2016 | VAI | Human Drugs · Drug Quality Assurance | 995558 |
| January 8, 2015 | NAI | Human Drugs, Medical Devices & Rad Health · Compliance: Devices | 913214 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Teva Pharmaceutical Industries Ltd.
Stock ticker
TEVA
Exchange
NYSE
Share price
$43.65
Market cap
$50.9B
Price as of
November 13, 2026
FEI Number
3003414719
Address
2, Hamarpeh Street, Jerusalem, Israel
Country
Israel
ID: 8d962606-fec1-46ca-afc3-14ac64f15c87